Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety

Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.

Detalles Bibliográficos
Autores principales: Jørgensen, Astrid‐Helene Ravn, Holm, Jesper Grønlund, Thomsen, Simon Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752321/
https://www.ncbi.nlm.nih.gov/pubmed/33363841
http://dx.doi.org/10.1002/ccr3.3090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752321/
https://www.ncbi.nlm.nih.gov/pubmed/33363841
http://dx.doi.org/10.1002/ccr3.3090

Ejemplares similares